Concepedia

Marta Nyakas

MN

40

Publications

7.5K

Citations

31

H-Index

2011

Active since

Affiliations

Oslo University Hospital(Current)

Institut Gustave Roussy

Melanoma Institute Australia

The University of Sydney

Royal North Shore Hospital

Marta Nyakas is an author at Oslo University Hospital specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2011–2024

40

Publications

40

Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma

Keith T. Flaherty, Caroline Robert, Peter Hersey et al. · New England Journal of Medicine · 2012 · 2.1K citations · Full text

Adjuvant Dabrafenib plus Trametinib in Stage III<i>BRAF</i>-Mutated Melanoma

Georgina V. Long, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial

Paolo A. Ascierto, Michele Del Vecchio, Caroline Robert et al. · The Lancet Oncology · 2017 · 483 citations

, , +8

Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma

Reinhard Dummer, Axel Hauschild, Mario Santinami et al. · New England Journal of Medicine · 2020 · 397 citations · Full text

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma

Einar Osland Vik-Mo, Marta Nyakas, Birthe Mikkelsen et al. · Cancer Immunology Immunotherapy · 2013 · 302 citations · Full text

Rows per page

1–5 of 40